167 related articles for article (PubMed ID: 36792578)
1. ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer.
Xie W; Han Z; Zuo Z; Xin D; Chen H; Huang J; Zhu S; Lou H; Yu Z; Chen C; Chen S; Hu Y; Huang J; Zhang F; Ni Z; Shen X; Xue X; Lin K
Cell Death Dis; 2023 Feb; 14(2):124. PubMed ID: 36792578
[TBL] [Abstract][Full Text] [Related]
2. Mislocalization or reduced expression of Arf GTPase-activating protein ASAP1 inhibits cell spreading and migration by influencing Arf1 GTPase cycling.
Liu Y; Yerushalmi GM; Grigera PR; Parsons JT
J Biol Chem; 2005 Mar; 280(10):8884-92. PubMed ID: 15632162
[TBL] [Abstract][Full Text] [Related]
3. ADP ribosylation factor guanylate kinase 1 promotes the malignant phenotype of gastric cancer by regulating focal adhesion kinase activation.
Zhang S; Luo Q; Feng R; Yang F; Xu Q; Chen X; Yang S
Life Sci; 2021 May; 273():119264. PubMed ID: 33639150
[TBL] [Abstract][Full Text] [Related]
4. CD2AP inhibits metastasis in gastric cancer by promoting cellular adhesion and cytoskeleton assembly.
Xie W; Chen C; Han Z; Huang J; Liu X; Chen H; Zhang T; Chen S; Chen C; Lu M; Shen X; Xue X
Mol Carcinog; 2020 Apr; 59(4):339-352. PubMed ID: 31989722
[TBL] [Abstract][Full Text] [Related]
5. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
6. RhoC protein stimulates migration of gastric cancer cells through interaction with scaffold protein IQGAP1.
Wu Y; Chen YC; Sang JR; Xu WR
Mol Med Rep; 2011; 4(4):697-703. PubMed ID: 21537845
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
Bourguignon LY; Gilad E; Rothman K; Peyrollier K
J Biol Chem; 2005 Mar; 280(12):11961-72. PubMed ID: 15655247
[TBL] [Abstract][Full Text] [Related]
8. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
9. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
Zeng M; Li B; Yang L; Guan Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
[TBL] [Abstract][Full Text] [Related]
10. ASAP1 mediates the invasive phenotype of human laryngeal squamous cell carcinoma to affect survival prognosis.
Li M; Tian L; Yao H; Lu J; Ge J; Guo Y; Liu M; Xiao H
Oncol Rep; 2014 Jun; 31(6):2676-82. PubMed ID: 24788532
[TBL] [Abstract][Full Text] [Related]
11. Rho GTPase-activating protein 35 suppresses gastric cancer metastasis by regulating cytoskeleton reorganization and epithelial-to-mesenchymal transition.
Sun Y; Du R; Shang Y; Liu C; Zheng L; Sun R; Wang Y; Lu G
Bioengineered; 2022 Jun; 13(6):14605-14615. PubMed ID: 35758029
[TBL] [Abstract][Full Text] [Related]
12. The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton.
Randazzo PA; Andrade J; Miura K; Brown MT; Long YQ; Stauffer S; Roller P; Cooper JA
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4011-6. PubMed ID: 10725410
[TBL] [Abstract][Full Text] [Related]
13. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer.
Cheng Z; Liu F; Wang G; Li Y; Zhang H; Li F
Cell Signal; 2014 Dec; 26(12):2667-73. PubMed ID: 25152372
[TBL] [Abstract][Full Text] [Related]
14. The Arf GTPase-activating Protein, ASAP1, Binds Nonmuscle Myosin 2A to Control Remodeling of the Actomyosin Network.
Chen PW; Jian X; Heissler SM; Le K; Luo R; Jenkins LM; Nagy A; Moss J; Sellers JR; Randazzo PA
J Biol Chem; 2016 Apr; 291(14):7517-26. PubMed ID: 26893376
[TBL] [Abstract][Full Text] [Related]
15. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
16. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
[TBL] [Abstract][Full Text] [Related]
17. Loss of ASAP1 in the MMTV-PyMT model of luminal breast cancer activates AKT, accelerates tumorigenesis, and promotes metastasis.
Schreiber C; Gruber A; Roßwag S; Saraswati S; Harkins S; Thiele W; Foroushani ZH; Munding N; Schmaus A; Rothley M; Dimmler A; Tanaka M; Garvalov BK; Sleeman JP
Cancer Lett; 2022 May; 533():215600. PubMed ID: 35181478
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination of the scaffold protein IQGAP1 diminishes its interaction with and activation of the Rho GTPase CDC42.
Gorisse L; Li Z; Wagner CD; Worthylake DK; Zappacosta F; Hedman AC; Annan RS; Sacks DB
J Biol Chem; 2020 Apr; 295(15):4822-4835. PubMed ID: 32094223
[TBL] [Abstract][Full Text] [Related]
19. Expression of ASAP1 and FAK in gastric cancer and its clinicopathological significance.
Luo Q; Zhang S; Zhang D; Yuan F; Chen X; Yang S
Oncol Lett; 2020 Jul; 20(1):974-980. PubMed ID: 32566028
[TBL] [Abstract][Full Text] [Related]
20. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
Tao Y; Sun C; Zhang T; Song Y
Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
